Down-regulation of Gal-3 is also related to reducing tumor growth and increasing the sensitivity of tumor cells to chemotherapy drugs due to the protein’s involvement in apoptosis-resistance and drug-resistance pathways [79]. The gene discussed is LGALS3; the disease is neoplasm.